Home › Funds › Parkside Financial Bank & Trust › ROIV
Parkside Financial Bank & Trust position in ROIV
ROIVANT SCIENCES LTD · Health Care
Parkside Financial Bank & Trust reported holding 1,329,184 shares of ROIV (ROIVANT SCIENCES LTD) in its Q3 2026 13F filing — a position valued at US$48.6M, representing 3.33% of its reported portfolio and ranking #4 among its reported holdings. Parkside Financial Bank & Trust has disclosed ROIV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Parkside Financial Bank & Trust's ROIV position evolved
Parkside Financial Bank & Trust first disclosed a stake in ROIV in Q3 2023 at 195 shares (US$2K). The position peaked in Q3 2026 at 1,329,184 shares, worth US$48.6M. Across 13 filings, Parkside Financial Bank & Trust increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 1,329,184 shares valued at US$48.6M. Notable position changes include a 297922% increase in Q1 2025 (shares rose 12% over the following quarter), a 113% increase in Q2 2025 (shares rose 34% over the following quarter), a 67% increase in Q4 2025 (shares rose 28% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 195 | $2.28K | New |
| Q4 2023 | 195 | $2.19K | Hold |
| Q1 2024 | 195 | $2.06K | Hold |
| Q2 2024 | 195 | $2.06K | Hold |
| Q3 2024 | 195 | $2.25K | Hold |
| Q4 2024 | 206 | $2.44K | Add |
| Q1 2025 | 613.93K | $6.19M | Add |
| Q2 2025 | 1.31M | $14.76M | Add |
| Q3 2025 | 698.52K | $10.57M | Reduce |
| Q4 2025 | 1.17M | $25.32M | Add |
| Q1 2026 | 1.33M | $36.82M | Add |
| Q2 2026 | 1.33M | $47.04M | Hold |
| Q3 2026 | 1.33M | $48.61M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ROIV and 13F data
ROIV (ROIVANT SCIENCES LTD) is a Health Care company. 62 other funds we track also report a position in ROIV — the largest reported positions include QVT Financial LP (US$839.6M), Farallon Capital Management (US$506.4M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$506.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ROIV
- QVT Financial LP 23.72M sh · $839.56M · Q2 2026
- Farallon Capital Management 14.31M sh · $506.40M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 14.31M sh · $506.40M · Q2 2026
- ADAGE CAPITAL PARTNERS GP, L.L.C. 10.35M sh · $366.26M · Q2 2026
- PERCEPTIVE ADVISORS LLC 8.09M sh · $286.14M · Q2 2026
- Patient Square Capital LP 7.71M sh · $281.99M · Q3 2026
- Darwin Global Management, Ltd. 6.75M sh · $234.33M · Q2 2026
- Rubric Capital Management LP 6.00M sh · $212.34M · Q2 2026
- BAKER BROS. ADVISORS LP 4.72M sh · $166.93M · Q2 2026
- Affinity Asset Advisors, LLC 3.75M sh · $132.71M · Q2 2026
- ADAR1 Capital Management, LLC 3.16M sh · $111.73M · Q2 2026
- Maverick Capital 2.83M sh · $100.12M · Q2 2026
More on Parkside Financial Bank & Trust
FAQ
How long has Parkside Financial Bank & Trust held ROIV?
Parkside Financial Bank & Trust has disclosed ROIV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Parkside Financial Bank & Trust's current position in ROIV?
As of Q3 2026, Parkside Financial Bank & Trust holds 1.33M shares of ROIV (ROIVANT SCIENCES LTD), valued at $48.61M, representing 3.33% of its reported portfolio and ranking #4.
Has Parkside Financial Bank & Trust been buying or selling ROIV?
In the latest 13F filing (Q3 2026), Parkside Financial Bank & Trust held unchanged its position in ROIV. The position peaked in Q3 2026 at 1.33M shares.
Which other funds hold ROIV?
Other major institutional holders of ROIV include QVT Financial LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 62 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.